Publication & Citation Trends
Publications
0 total
Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial.
Cited by 0
Semantic Scholar
Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study.
Cited by 3
Semantic Scholar
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial OA
Cited by 28
Semantic Scholar
Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
Cited by 24
Semantic Scholar
A novel RIP1-mediated canonical WNT signaling pathway that promotes colorectal cancer metastasis via β -catenin stabilization-induced EMT OA
Cited by 17
Semantic Scholar
Health-related quality of life (HRQoL) in the phase 3 KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) versus placebo plus gem/cis for advanced biliary tract cancer (BTC).
Cited by 6
Semantic Scholar
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial OA
Cited by 456
Semantic Scholar
Research Topics
Helicobacter pylori-related gastroenterology studies
(2)
Esophageal Cancer Research and Treatment
(2)
Gastric Cancer Management and Outcomes
(2)
Wnt/β-catenin signaling in development and cancer
(1)
Gastrointestinal Tumor Research and Treatment
(1)
Affiliations
Korea University
Korea University Medical Center